Brazil authorised the Butantan-DV single-dose dengue vaccine on 26 November for people aged 12 to 59. Health experts say a single dose could improve protection in remote and hard-to-reach areas such as the Amazon. The approval comes after Brazil's large dengue epidemic in 2024, when 6.4 million cases and 5,972 deaths were reported. Globally, more than 14 million cases were reported in 2024 and 12.6 million of those were in Latin America.
Late-stage trials in Brazil with 16,000 volunteers over nearly a decade showed 74.7% overall efficacy and 91.6% efficacy against severe dengue. Recent data indicates 100% efficacy against hospitalisations. Butantan said the vaccine will join the national immunisation programme in early 2026. More than 1 million doses are ready, and a partnership with WuXi Vaccines aims to produce 60 million doses over the next two years.
Difficult words
- authorised — give official permission or approval
- single-dose — vaccine given in one injection
- remote — far away from towns or cities
- epidemic — many people sick at the same time
- efficacy — how well a medicine or vaccine works
- severe — very bad or serious in effect
- immunisation — program to give vaccines to many people
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Do you think a single-dose vaccine is useful in remote places? Why?
- How would you feel if a vaccine had high protection against severe illness?
- Have you or someone you know had a vaccine that helped prevent a serious disease?
Related articles
AI Could Train the Next Generation of Surgeons
Artificial intelligence may assist medical students by giving real-time feedback on their surgical skills. This tool aims to help address the shortage of surgeons.
AI Tools Transforming Tuberculosis Detection
Researchers are introducing AI tools that can improve how tuberculosis is detected and treated. These innovations aim to help communities with limited access to traditional diagnostics.
Success of Long-Lasting HIV Drug Depends on Pricing
Healthcare experts say the availability and affordable price of lenacapavir, a new HIV prevention drug, are crucial for its success.
Environmental Crisis from Mining Activities in the DRC
Mining activities in the Democratic Republic of the Congo are causing serious environmental and health issues for local communities. Chinese companies are often at the center of these troubles, neglecting environmental standards.
Soybean oil linked to weight gain in mice
A University of California, Riverside study found that a high-fat diet rich in soybean oil made most mice gain weight. Engineered mice with a different liver protein did not gain weight; oxylipins from linoleic acid may be involved.
New Antibody Test: Fast, No Blood Needed
A new test detects antibodies quickly without blood. It could help monitor infections and vaccine effectiveness.